we established four treatment
groups: (1) control group without NEFAs, (2) basal physiological
NEFA concentrations of 72 mM, ranging up until (3)
360 mM in moderate elevated though physiological concentrations,
and (4) 720 mM in high pathologic and
potentially cytotoxic metabolic conditions.